3647 results for «819»

Filter By

3647 results

New frontiers in coronary disease treatment

21 May 2026 – From EuroPCR 2026

Examine recent advances in coronary disease treatment focusing on drug-eluting stents versus drug-coated balloon strategies. This session presents real-world data on lesion preparation, sex-specific outcomes, physiological disease patterns, and procedural factors influencing PCI success.

Pharmacology without borders, from coronary artherostenosis to radial artery

21 May 2026 – From EuroPCR 2026

This session delves into the expansive role of pharmacology in interventional cardiology, addressing topics ranging from coronary atherostenosis to radial artery management. Key discussions include the real-world efficacy and safety of intravenous cangrelor-assisted PCI in chronic coronary syndromes, comparative analysis of intra-arterial verapamil versus placebo for...

Focus on heart failure: from acute to chronic

21 May 2026 – From EuroPCR 2026

This comprehensive session delves into the spectrum of heart failure management, from acute presentations to chronic conditions. Key topics include the cardio-hepatic syndrome and right ventricular dysfunction in HFmrEF, prognostic implications of heart failure etiologies, and innovative approaches such as AI-assisted echocardiography for early detection of...

Strategies to enhance bifurcation PCI outcomes

21 May 2026 – From EuroPCR 2026

This session addresses strategies to optimize outcomes in coronary bifurcation PCI. It evaluates the impact of cutting and scoring balloons versus non-compliant balloons on stent expansion, predictors of target vessel revascularization using the POKI technique, and compares stent and non-stent approaches in side branch myocardial infarction...

Aortic stenosis: from diagnostic to treatment

21 May 2026 – From EuroPCR 2026

This session provides an in-depth review of contemporary management of aortic stenosis, covering diagnostic advancements, temporal trends, and treatment outcomes. It includes insights from the LAPLACE-TAVI registry focusing on low-risk patients, discusses the growing feasibility of day-case TAVI procedures, compares transcatheter and surgical valve replacements in...

All you need to know of DAPT in ACS

21 May 2026 – From EuroPCR 2026

This session provides an in-depth review of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS), focusing on strategies for safe de-escalation and P2Y12 inhibitor monotherapy to reduce bleeding risk without compromising ischemic protection. It also covers optimizing antithrombotic therapy in patients on oral anticoagulation and...

All you need to know of DAPT in ACS

A series of complex real-word challenges STEMI treatment from very different countries

21 May 2026 – From EuroPCR 2026

This session showcases a series of complex STEMI treatment challenges from diverse international settings, highlighting difficult coronary anatomies and complicated procedures. It discusses nuanced clinical scenarios where artery recanalisation does not always equate to reperfusion, and presents stepwise approaches to managing multivessel disease, renal failure, and...

INOCA/ANOCA: view insights from clinical practice

19 May 2026 – From EuroPCR 2026

This session provides in-depth clinical insights into INOCA and ANOCA by exploring innovative invasive assessments of coronary microcirculation and vasoreactivity, with a focus on diabetic populations and sex differences. It reviews distinct IMR-based phenotypes differentiating flow versus pressure-driven microvascular dysfunction, and the role of invasive hemodynamics...

Bifurcation and heavily calcified lesions

21 May 2026 – From EuroPCR 2026

This session addresses the evaluation and treatment of bifurcation and heavily calcified coronary lesions. It includes case-based discussions on complex left main PCI and the use of drug-coated balloons (DCB) for bifurcation lesions and in-stent restenosis, providing evidence-based approaches to optimize outcomes in these challenging lesion...

Multivessel complications: what can go wrong

21 May 2026 – From EuroPCR 2026

This session highlights complications encountered in multivessel coronary interventions, presenting complex cases such as lost stents, coronary perforations, shaft fractures, early subacute stent thrombosis, and rare triple vessel thrombosis. It emphasizes practical management strategies for these challenging scenarios in contemporary interventional cardiology.

Multivessel complications: what can go wrong

New data on intracoronary imaging-guided interventions

21 May 2026 – From EuroPCR 2026

This session presents new data on intracoronary imaging-guided interventions, comparing outcomes of angiography-derived FFR and IVUS-guided PCI over two years, as well as OCT versus IVUS for intermediate left main stenosis. It further evaluates high-risk non-culprit lesions post-myocardial infarction, the role of coronary lipid burden in...

New data on intracoronary imaging-guided interventions

News from drug-eluting therapies in 2026

19 May 2026 – From EuroPCR 2026

This session presents the latest advancements in drug-eluting therapies for 2026, including predictors of target lesion failure after drug-coated balloon treatment, clinical outcomes related to stenting length, and novel insights into sirolimus transfer evidenced by in vivo OCT imaging.

Planning and execution of re-do TAVI (TAV-in-TAV) procedures

19 Nov 2023 – From PCR London Valves 2023

Redo TAVI poses challenges but can be managed with a step-by-step procedural plan, ensuring better acute and long-term outcomes. Guidelines and industry resources aid in planning, yet forthcoming registry studies are essential for further data and insights. Watch this session to find out more!

Planning and execution of re-do TAVI (TAV-in-TAV) procedures

How to treat my patient with primary mitral regurgitation?

20 Nov 2023 – From PCR London Valves 2023

In this session, study the different cases of primary mitral regurgitation in detail, with diagrams, videos and even recommendations, to find out when to opt for replacement rather than repair, how to better manage transcatheter mitral replacement, and how to get to grips with endoscopic mitral...

How to treat my patient with primary mitral regurgitation?

How to treat my patient with combined aortic and mitral valve disease

20 Nov 2023 – From PCR London Valves 2023

Explore this session to gain insights into diverse treatment options for combined heart valve disease. Examine the distinctions between surgical and transcatheter approaches, understanding their nuances, the sequential order of treatment and technical considerations crucial for transcatheter interventions.

How to treat my patient with combined aortic and mitral valve disease

Challenging CTO interventions: part 3

07 Dec 2023 – From GulfPCR-GIM 2023

In this session, broaden your knowledge in CTO treatment by exploring these diverse cases: delve into the complexities of managing double CTO lesions with ACS, gain insights into the ambiguous ostium antegrade CTO, and explore effective techniques such as the semi stent crush technique for closing...

Welcome to GulfPCR Valves 2023

05 Dec 2023 – From GulfPCR-GIM 2023

Find out more about this very first edition of GulfPCR Valves by discovering its Course directors, its objectives, its programme, its partners and its interactivity. If you are a heart valve interventionist or an imager, and you have a keen interest in valve disease, and TAVI in...

Welcome to GulfPCR Valves 2023

TAVI for bicuspid aortic stenosis patients - Recorded cases

05 Dec 2023 – From GulfPCR-GIM 2023

Discover two clinical cases of optimising TAVI procedure in bicuspid aortic valve patients, taking into account the current sizing options in such anatomy.

  • An 84-year-old woman with a history of LAD PCI in 2020, presented a symptomatic severe aortic stenosis and grade 3 regurgitation with a preserved LV...
TAVI for bicuspid aortic stenosis patients - LIVE case

TAVI and access: alternating is wise

16 Jan 2024 – From GulfPCR-GIM 2023

Given that 10-20% of patients have restricted or even impossible femoral access, it is important, for both procedural and patient safety, that alternative access is sometimes considered. Learn what options are available, whether surgical or transcatheter, depending on the patient, and how to put these choices into...

TAVI and access: alternating is wise

Newer generation self-expanding platform: technical optimisation for common clinical challenges

05 Dec 2023 – From GulfPCR-GIM 2023

The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...

Newer generation self-expanding platform: technical optimisation for common clinical challenges
Didn’t find what you were looking for?